Expert Opinion on Drug Safety
Volume 19, 2020 - Issue 10
Open access
9,413
Views
23
CrossRef citations to date
0
Altmetric
Review
CGRP inhibitors for migraine prophylaxis: a safety review
Eduardo Rivera-Mancillaa Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The NetherlandsView further author information
, Carlos M. Villalónb Department of Pharmacobiology, Cinvestav-Coapa, Mexico City, MexicoView further author information
& Antoinette MaassenVanDenBrinka Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0001-7176-126XView further author information
https://orcid.org/0000-0001-7176-126XView further author information
Pages 1237-1250
|
Received 09 Jun 2020, Accepted 13 Aug 2020, Published online: 21 Sep 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.